Effect of in vitro and in vivo administration of dexamethasone on rat macrophage functions: Comparison between alveolar and peritoneal macrophages

European Respiratory Journal

Volumn 9, Issue 2, 1996, Pages 301-306

  Nakamura, Y ^a   Murai, T ^a   Ogawa, Y ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Alveolar macrophages; Dexamethasone; Perioneal macrophages; Phagocytosis; Tumour necrosis factor

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MALE; PHAGOCYTOSIS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030047982     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09020301     Document Type: Article

References (24)

1. Dannenberg JAM. The anti-inflammantory effects of glucocorticosteroids: a brief review of the literature. Inflammation 1979; 3: 329-343.
2. Gupps TR, Fanei AS. Glucocorticoid-mediated immunoregulation in man. Immunol Rev 1982; 65: 133.
3. Gallin JI, Goldstein IM, Sinderman R. Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Sinderman R, eds. Adrenal Corticosteroids. New York, Raven Press, 1988; pp. 877-895.
4. Russo-Marie F. Macrophage and glucocorticoids. J Neuroimmunol 1992; 40: 281-286.
5. Jain NC. Monocytes and macrophages. In: Schaluis Veterinary Hematology. 4th edn. 1986; pp. 768-789.
6. Normann SJ, Sorkin E. Distinction of macrophage subpopulations: measurement of functional cell parameters by flow cytometory. Macrophages and natural killer cells: regulation and function. In: Normann SJ, Sorkin E, eds. New York, Plenum Press, 1982; 155: pp. 453-459.
7. Normann SJ, Sorkin E. Macrophage functional heterogeneity. Macrophages and natural killer cells: regulation and function. In: Normann SJ, Sorkin E, eds. New York, Plenum Press, 1982; 155: pp. 435-452.
8. Weinberg DS, Unaue ER. Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria manocytogenes. J Immunol 1981; 126: 794-799.
9. Schaffner A, Douglas H, Braude AI, Davis CE. Killing of aspergillus spores depends on the anatomical source of the macrophage. Infect Immun 1983; 42: 1109-1115.
10. Kaitreider HB, Caldwell JL, Byrd PK. The capacity of normal murine alveolar macrophages to function as antigen-presenting cells for the inhibition of primary antibody-forming cell responses to sheep erythrocytes in vitro. Am Rev Respir Dis 1986; 133: 1097-1104.
11. Holt PG, Warner LA, Popadimitriou JM. Alveolar macrophages: functional heterogeneity within macrophage populations from the rat lung. Aust J Exp Biol Med Sci 1982; 60: 607.
12. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141: 471-501.
13. Oren R, Farnham AE, Saito K, Melofsky E, Karnovsky ML. Metabolic patterns in three types of phagocytizing cells. J Cell Biol 1963; 17: 487-501.
14. Nibbering P, Leijh P, Furth R. Quantitative immunocytochemical characterization of mononuclear phagocytes. I. Monoblasts, promonocytes, monocytes, and peritoneal and alveolar macrophages. Cell Immunol 1987; 105: 374-385.
15. Lipscomb M, Lyons C, Miller L, et al. Human alveolar macrophages: HLA-DR positive macrophages that are poor stimulators of the mixed leukocyte reaction. J Immunol 1986; 136: 497-504.
16. Nibbering P, Barselaar MT, Gevel J, Leigh P, Furth R. Deficient intracellular killing of bacteria by marine alveolar macrophages. Am J Respir Cell Mol Biol 1989; 1: 417-422.
17. Rich E, Panuska J, Wallis R, Wolf C, Leonard M, Ellner J. Dysco-oridinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am Rev Respir Dis 1989; 139: 1010-1016.
18. Becker J, Grasson RJ. Suppression of phagocytosis by dexamethasone in macrophage cultures: inability of arachidonic acid, indomethacin and nordihydroguaretic acids to reverse the inhibitory response mediated by a steroid-inducible factor. Int J Immunopharmacol 1985; 7: 839-847.
19. Mbawuike IN, Herscowits HB. Role of activation in alveolar macrophage-mediated suppression of the plaque-forming cell response. Infect Immun 1988; 56: 577-581.
20. Beutler B, Krochin N, Milsark JW, Luedke C, Cerami A. Control of cachectic (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986; 232: 977-980.
21. Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985; 76: 1755-1764.
22. Schaffner A, Schaffner T. Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanisms and dependence on the state of activation. Rev Infect Dis 1987; 9: S620-S629.
23. Strieter RM, Remick DG, Lynch JP, et al. Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peritoneal blood monocytes: a cellular and molecular analysis. Am J Respir Cell Mol Biol 1989; 1: 57-63.
24. Siegel SC. Corticosteroid agents: overview of corticoid therapy. J Allergy Clin Immunol 1985; 76: 312-320.